Universe Pharmaceuticals

General Information
Business:

We are a pharmaceutical company based in Jiangxi, China, specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (“TCMD”) products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. We have registered and obtained approval for 26 varieties of TCMD products from the National Medical Products Administration (the “NMPA”), and we currently produce 13 varieties of TCMD products, which are sold in approximately 261 cities of 30 provinces in China as of the date of this prospectus. In addition, through our subsidiary Jiangxi Universe Pharmaceuticals Commercial Trade Co., Ltd. (“Universe Trade”), we sell not only our own TCMD products, but also biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (“TCMPs”), and dietary supplements manufactured by third-party pharmaceutical companies.

 

Industry: Pharmaceuticals
Employees: 56
Founded: 1998
Contact Information
Address 265 Jingjiu Avenue Jinggangshan Economic and Technological Development Zone Ji’an, Jiangxi, China 343100
Phone Number +86-0796-8403309
Web Address http://www.dzrzy.com
View Prospectus: Universe Pharmaceuticals
Financial Information
Market Cap $126mil
Revenues $30.7 mil (last 12 months)
Net Income $8.4 mil (last 12 months)
IPO Profile
Symbol UPC
Exchange NASDAQ
Shares (millions): 5.0
Price range $5.00 - $5.00
Est. $ Volume $25.0 mil
Manager / Joint Managers Univest Securities, LLC
CO-Managers -
Expected To Trade: 3/23/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change